Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Kaemmerer, Peer W.; Tribius, Silke; Cohrs, Lena et al.
Adjuvant Radiotherapy in Patients with Squamous Cell Carcinoma of the Oral Cavity or Oropharynx and Solitary Ipsilateral Lymph Node Metastasis (pN1)-A Prospective Multicentric Cohort StudyCANCERS. Bd. 15. H. 6. 2023
Heinzelbecker, Julia; Spieler, Natalie; Kuehn, Michael et al.
Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients: Long-term follow-up of a randomized phase 3 trialUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. Bd. 41. H. 8. 2023 S. 356e19-356e30
Park-Simon, Tjoung-Won; Mueller, Volkmar; Jackisch, Christian et al.
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer (EBC): Update 2023BREAST CARE. Bd. 18. H. 4. 2023 S. 288-304
Thill, Marc; Kolberg-Liedtke, Cornelia; Albert, Ute-Susann et al.
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023BREAST CARE. Bd. 18. H. 4. 2023 S. 305-314
Heitz, Florian; Marth, Christian; Henry, Stephanie et al.
AGO-OVAR 28/ENGOT-ov57. Niraparib alone versus niraparib in combination with bevacizumab in patients with carboplatin-taxane-based chemotherapy in advanced ovarian cancer: a multicenter randomized phase III trialINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023
Berning, Philipp; Schmitz, Norbert; Ngoya, Maud et al.
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysisLEUKEMIA. 2023
Ziegler, Nicole; Cortes-Lopez, Mariela; Alt, Francesca et al.
Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALLONCOIMMUNOLOGY. Bd. 12. H. 1. 2023
Czogalla, Bastian; Trillsch, Fabian; Mahner, Sven et al.
Anastomotic leakage following bowel resection in radical cytoreductive surgery for ovarian cancer: A subgroup analysis of the prospective AGO-OVAR.OP3/LIONJOURNAL OF CLINICAL ONCOLOGY. Bd. 41. H. 16. 2023
Decker, Thomas; Luedtke-Heckenkamp, Kerstin; Melnichuk, Luidmila et al.
Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)BREAST. Bd. 72. 2023
Hoeffken, Klaus; Bruns, Christiane; Schmidberger, Heinz
Are studies good?ONKOLOGIE. Bd. 29. H. 5. 2023 S. 384-385